Current and historical daily PE Ratio for Instem PLC (
LSE:INS
) from 2010 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Instem PLC stock (LSE:INS) PE ratio as of Jun 10 2024 is 58.45.
More Details
Instem PLC (LSE:INS) PE Ratio (TTM) Chart
Instem PLC (LSE:INS) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1131
- 1
- 2
- 3
- 4
- 5
- 6
- 13
| Instem PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 58.5 | 2023-09-18 | 58.1 |
| 2023-11-20 | 58.5 | 2023-09-15 | 58.1 |
| 2023-11-17 | 58.5 | 2023-09-14 | 58.1 |
| 2023-11-16 | 58.5 | 2023-09-13 | 58.1 |
| 2023-11-15 | 58.3 | 2023-09-12 | 58.1 |
| 2023-11-14 | 58.3 | 2023-09-11 | 58.1 |
| 2023-11-10 | 58.3 | 2023-09-08 | 58.1 |
| 2023-11-09 | 58.3 | 2023-09-07 | 58.1 |
| 2023-11-08 | 58.3 | 2023-09-06 | 58.1 |
| 2023-11-07 | 58.5 | 2023-09-05 | 58.5 |
| 2023-11-06 | 58.5 | 2023-09-04 | 58.1 |
| 2023-11-03 | 58.3 | 2023-09-01 | 58.1 |
| 2023-11-02 | 58.3 | 2023-08-31 | 58.1 |
| 2023-11-01 | 53.5 | 2023-08-30 | 58.1 |
| 2023-10-31 | 53.9 | 2023-08-29 | 41.5 |
| 2023-10-30 | 53.9 | 2023-08-28 | 41.5 |
| 2023-10-27 | 53.5 | 2023-08-25 | 41.5 |
| 2023-10-26 | 53.5 | 2023-08-24 | 41.7 |
| 2023-10-25 | 53.5 | 2023-08-23 | 41.7 |
| 2023-10-24 | 53.5 | 2023-08-22 | 41.7 |
| 2023-10-23 | 53.2 | 2023-08-21 | 41.9 |
| 2023-10-20 | 53.2 | 2023-08-18 | 43.0 |
| 2023-10-19 | 52.1 | 2023-08-17 | 42.4 |
| 2023-10-18 | 52.1 | 2023-08-16 | 42.4 |
| 2023-10-17 | 52.1 | 2023-08-15 | 42.3 |
| 2023-10-16 | 52.1 | 2023-08-14 | 43.7 |
| 2023-10-13 | 51.8 | 2023-08-11 | 43.3 |
| 2023-10-12 | 57.6 | 2023-08-10 | 44.0 |
| 2023-10-11 | 57.6 | 2023-08-09 | 44.0 |
| 2023-10-10 | 57.4 | 2023-08-08 | 44.0 |
| 2023-10-09 | 57.8 | 2023-08-07 | 44.4 |
| 2023-10-06 | 58.1 | 2023-08-04 | 44.4 |
| 2023-10-05 | 58.1 | 2023-08-03 | 44.4 |
| 2023-10-04 | 57.9 | 2023-08-02 | 44.5 |
| 2023-10-03 | 58.5 | 2023-08-01 | 44.5 |
| 2023-10-02 | 58.5 | 2023-07-31 | 43.1 |
| 2023-09-29 | 58.6 | 2023-07-28 | 43.1 |
| 2023-09-28 | 57.8 | 2023-07-27 | 43.0 |
| 2023-09-27 | 58.3 | 2023-07-26 | 43.0 |
| 2023-09-26 | 57.8 | 2023-07-25 | 43.0 |
| 2023-09-25 | 58.1 | 2023-07-24 | 43.0 |
| 2023-09-22 | 58.1 | 2023-07-21 | 43.0 |
| 2023-09-21 | 58.1 | 2023-07-20 | 43.1 |
| 2023-09-20 | 58.1 | 2023-07-19 | 43.1 |
| 2023-09-19 | 58.1 | 2023-07-18 | 43.3 |
Instem PLC (LSE:INS) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Instem PLC
NAICS : 518210
ISIN : GB00B3TQCK30
Description
Instem PLC acts as a supplier of IT applications and technology-enabled outsourced services to the global health and life sciences community. Its segments include Study Management, Regulatory Solutions, and In Silico Solutions, Clinical Trial Acceleration. The company generates maximum revenue from Study Management. Geographically, it derives a majority of its revenue from theĀ United StatesĀ and also has a presence in the Europe and Rest of the World. Its portfolio of software solutions includes Instem Cloud, SEND Data Conversion, KnowledgeScan, SENDReady Consulting, Solution Deployment, Validation, Data Management, and Regulatory Information Management.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers